Mandel-Brehm Josh bought PMN
May 20, 2026 · Form 4 insider transaction
Mandel-Brehm Josh bought 11,000 shares of ProMIS Neurosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,000
Price
$0.00
Total value
N/A
InsiderMandel-Brehm Josh
Role—
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 20, 2026
Filing dateMay 22, 2026
Shares owned after11,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to this option vested upon grant with the remaining shares vesting ratably over thirty-six months, subject to continued service on the Board.